GL1X · GenesisL1 explorer

MolNFT v1 · #114448 · protein

Crystal structure of the cysteine-rich domain of human frizzled 4 - crystal form II

5BPQ · Frizzled-4: “Crystal structure of the cysteine-rich domain of human frizzled 4 - crystal form II”. X-ray diffraction, 2 ligands (NAG, CL), 5 pockets (best druggability 0.57). MolNFT v1 #114448 on GenesisL1: 3D structure, binding…

PDB
5BPQ
Type
protein
Length
475 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Frizzled-4
UniProt
Q9ULV1
Ligands
NAG, CL
Pockets
5 · best druggability 0.57

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, DFrizzled-4protein11941% helix, 12% strandQ9ULV1
CFrizzled-4protein11842% helix, 7% strandQ9ULV1

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A, B, C, D
  • CL · Chloride ion · ion

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11360.570.8328empty
22210.470.7431empty
3550.390.8012empty
4810.390.7714empty
5610.290.7316empty

Interfaces

2 interfaces between chains.

  • A–D · 715 Ų buried · 4 hydrogen bonds · protein-protein
  • A–B · 296 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 20 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 5BPQ · Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form II · the same entry in another collection · chain D against D, TM-score 1.00
  • Q9ULV1 · AlphaFold monomer V2.0 prediction for frizzled-4 (Q9ULV1) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.